USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an antiāIL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
SPONSORED CONTENT1 dose, once a month.Defends dogs against ticks and fleas and also protects against heartworm disease, roundworms, hookworms and tapeworms. + Learn More